Research Article
Study on Pharmacokinetic and Bioavailability of Tamarixetin after Intravenous and Oral Administration to Rats
Table 5
Pharmacokinetic parameters of tamarixetin after intravenous and oral administration (n = 6).
| Parameters | Intravenous (2 mg/kg) | Oral administration (20 mg/kg) |
| Tmax (h) | 0.03 ± 0.00 | 0.61 ± 0.36 | Cmax (ng/mL) | 967.93 ± 899.16 | 49.72 ± 38.31 | AUC(0–24 h) (ng/mL·h) | 134.29 ± 74.53 | 163.63 ± 72.29 | AUC(0–∞) (ng/mL·h) | 138.63 ± 75.43 | 226.08 ± 122.53 | T1/2 (h) | 0.03 ± 0.01 | 9.68 ± 9.45 | MRT(0–24 h) (h) | 3.07 ± 2.54 | 6.81 ± 3.10 | MRT(0–∞) (h) | 4.21 ± 3.15 | 15.42 ± 10.43 |
|
|